Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04737031 · ClinicalTrials.gov registry record · NA
Improving Tobacco Treatment Rates for Outpatient Cancer Patients Who Smoke
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 2,146
- Enrollment target
NCT04737031 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 2,146 participants.
The verdict
NCT04737031, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,146 participants
- Enrollment target
Study Summary
The main purpose of this research study is to evaluate the effectiveness of "nudges" to clinicians, to patients, or to both in increasing Tobacco Use Treatment Service (TUTS) referral and engagement; and to explore clinician, patient, inner setting (e.g., clinic), and outer setting (e.g., payment structures) mechanisms related to TUTS referral and engagement. The investigators will employ rapid-cycle approaches to optimize the framing of nudges to clinicians and patients prior to initiating the trial and mixed methods to explore contextual factors and mechanisms. The investigators will conduct a four-arm pragmatic cluster randomize clinical trial to test the effectiveness of nudges to clinicians, nudges to patients, or nudges to both in increasing TUTS referral and engagement in cancer patients who smoke, vs. usual care (UC). The investigators hypothesize that each of the implementation strategy arms will significantly increase TUTS referral and engagement compared to UC and that the combination of nudges to clinicians and to patients will be the most effective.
Interventions
- OTHER Clinician Nudge
- OTHER Patient Nudge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,146 participants |
| Start Date | 2021-05-18 |
| Est. Completion | 2022-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04737031
The ClinicalTrials.gov registry entry for NCT04737031 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,146 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Clinician Nudge is the first listed.
NCT04737031 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04737031 about?
NCT04737031 is a clinical study titled "Improving Tobacco Treatment Rates for Outpatient Cancer Patients Who Smoke". The main purpose of this research study is to evaluate the effectiveness of "nudges" to clinicians, to patients, or to both in increasing Tobacco Use Treatment Service (TUTS) referral and engagement; and to explore clinician, patient, inner setting (e.g., clinic), and outer setting (e.g., payment st...
What is the current status of trial NCT04737031?
This trial is currently completed. It is a NA study. The enrollment target is 2,146 participants. The study started on 2021-05-18. Estimated completion is 2022-07-31.
What interventions are being tested in trial NCT04737031?
The interventions under investigation include: Clinician Nudge (OTHER), Patient Nudge (OTHER).
Who is sponsoring clinical trial NCT04737031?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.